Journal of Psychosomatic Research
Volume 65, Issue 4 , Pages 389-401 , October 2008

Stress management effects on perceived stress and cervical neoplasia in low-income HIV-infected women

  • Michael H. Antoni

      Affiliations

    • Department of Psychology, University of Miami, Miami, FL, USA
    • Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, FL, USA
    • Biobehavioral Oncology Program, Sylvester Comprehensive Cancer Center, Miami, FL, USA
    • Corresponding Author InformationCorresponding author. Department of Psychology, University of Miami, 5665 Ponce DeLeon Blvd, Rm 413, Coral Gables, FL 33124, USA. Tel.: +1 305 284 5466; fax: +1 305 284 1366.
  • ,
  • Deidre B. Pereira

      Affiliations

    • Department of Clinical and Health Psychology, University of Florida, Gainesville, FL, USA
  • ,
  • Ilona Marion

      Affiliations

    • Department of Psychology, University of Miami, Miami, FL, USA
  • ,
  • Nicole Ennis

      Affiliations

    • Department of Psychology, University of Miami, Miami, FL, USA
  • ,
  • Michele Peake Andrasik

      Affiliations

    • Department of Psychology, University of Miami, Miami, FL, USA
  • ,
  • Rachel Rose

      Affiliations

    • Department of Psychology, University of Miami, Miami, FL, USA
  • ,
  • Judith McCalla

      Affiliations

    • Department of Psychology, University of Miami, Miami, FL, USA
  • ,
  • Trudi Simon

      Affiliations

    • Department of Obstetrics and Gynecology, University of Miami Miller School of Medicine, Miami, FL, USA
  • ,
  • Mary Ann Fletcher

      Affiliations

    • Department of Psychology, University of Miami, Miami, FL, USA
    • Biobehavioral Oncology Program, Sylvester Comprehensive Cancer Center, Miami, FL, USA
    • Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA
  • ,
  • Joseph Lucci

      Affiliations

    • Biobehavioral Oncology Program, Sylvester Comprehensive Cancer Center, Miami, FL, USA
    • Department of Obstetrics and Gynecology, University of Miami Miller School of Medicine, Miami, FL, USA
  • ,
  • Jonell Efantis-Potter

      Affiliations

    • Department of Obstetrics and Gynecology, University of Miami Miller School of Medicine, Miami, FL, USA
  • ,
  • Mary Jo O'Sullivan

      Affiliations

    • Department of Obstetrics and Gynecology, University of Miami Miller School of Medicine, Miami, FL, USA

Received 12 August 2007 ,Revised 25 April 2008 ,Accepted 3 June 2008.

References 

  1. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518–527
  2. Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer—burden and assessment of causality. J Natl Cancer Inst Monogr. 2003;3–13
  3. Schmiedeskamp MR, Kockler DR. Human papillomavirus vaccines. Ann Pharmacother. 2006;40:1344–1352
  4. Palefsky JM, Holly EA. Chapter 6: immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr. 2003;41–46
  5. Penn I. Post-transplant malignancy: the role of immunosuppression. Drug Saf. 2000;23:101–113
  6. Man S. Human cellular immune responses against human papillomaviruses in cervical neoplasia. Expert Rev Mol Med. 1998;1998:1–19
  7. Appleby P, Beral V, Berrington de González A, Colin D, Franceschi S, Goodill A, et al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer. 2006;118:1481–1495
  8. Pereira DB, Antoni MH, Danielson A, Simon T, Efantis-Potter J, Carver CS, et al. Life stress and cervical squamous intraepithelial lesions in women with human papillomavirus and human immunodeficiency virus. Psychosom Med. 2003;65:427–434
  9. Antoni MH, Lutgendorf SK, Cole SW, Dhabhar FS, Sephton SE, McDonald PG, et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer. 2006;6:240–248
  10. Pantaleo G, Cohen OJ, Schacker T, Vaccarezza M, Graziosi C, Rizzardi GP, et al. Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: implications for antiviral therapy. Nat Med. 1998;4:341–345
  11. Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts DH, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the Women's Interagency HIV Study. Am J Public Health. 2006;96:1060–1065
  12. Antoni MH. Stress management and psychoneuroimmunology in HIV infection. CNS Spectr. 2003;8:40–51
  13. Antoni MH, Carrico AW, Duran RE, Spitzer S, Penedo F, Ironson G, et al. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosom Med. 2006;68:143–151
  14. Lechner SC, Antoni MH, Lydston D, LaPerriere A, Ishii M, Devieux J, et al. Cognitive-behavioral interventions improve quality of life in women with AIDS. J Psychosom Res. 2003;54:253–261
  15. Folkman S, Lazarus RS, Gruen RJ, DeLongis A. Appraisal, coping, health status, and psychological symptoms. J Pers Soc Psychol. 1986;50:571–579
  16. Minkoff H, Ahdieh L, Massad LS, Anastos K, Watts DH, Melnick S, et al. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS. 2001;15:2157–2164
  17. Cook RT. Alcohol abuse, alcoholism, and damage to the immune system—a review. Alcohol Clin Exp Res. 1998;22:1927–1942
  18. Pereira DB. Interventions for mothers during pregnancy and postpartum: behavioral and pharmacological approaches. In:  Chesney M,  Antoni MH editor. Innovative approaches to health psychology: prevention and treatment—Lessons learned from AIDS. Washington, DC: American Psychological Association Press; 2002;
  19. Antoni MH, Pereira DB. Cognitive behavioral stress management for HIV+ women with Human Papillomavirus infection: keeping hope alive. 1999. Ref Type: unpublished work.
  20. Sarason IG, Johnson JH, Siegel JM. Assessing the impact of life changes: development of the Life Experiences Survey. J Consult Clin Psychol. 1978;46:932–946
  21. Centers for Disease Control and Prevention . Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Morb Mortal Wkly Rep. 1987;36(Suppl 1):1S–15S
  22. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12:255–266
  23. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods. 2008;[in press]
  24. Babyak MA. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med. 2004;66:411–421
  25. Cruess S, Antoni M, Cruess D, Fletcher MA, Ironson G, Kumar M, et al. Reductions in herpes simplex virus type 2 antibody titers after cognitive behavioral stress management and relationships with neuroendocrine function, relaxation skills, and social support in HIV-positive men. Psychosom Med. 2000;62:828–837
  26. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. J Am Med Assoc. 1992;267:1244–1252
  27. Cacioppo JT, Kiecolt-Glaser JK, Malarkey WB, Laskowski BF, Rozlog LA, Poehlmann KM, et al. Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr virus. Horm Behav. 2002;42:32–41
  28. Glaser R, Kutz LA, MacCallum RC, Malarkey WB. Hormonal modulation of Epstein-Barr virus replication. Neuroendocrinology. 1995;62:356–361
  29. Bromberg-White JL, Meyers C. Comparison of the basal and glucocorticoid-inducible activities of the upstream regulatory regions of HPV18 and HPV31 in multiple epithelial cell lines. Virology. 2003;306:197–202
  30. Pater MM, Hughes GA, Hyslop DE, Nakshatri H, Pater A. Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA. Nature. 1988;335:832–835
  31. Bartholomew JS, Glenville S, Sarkar S, Burt DJ, Stanley MA, Ruiz-Cabello F, et al. Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells. Cancer Res. 1997;57:937–942
  32. Antoni MH, Cruess SE, Cruess DG, Kumar M, Lutgendorf S, Ironson G, et al. Cognitive-behavioral stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men. Ann Behav Med. 2000;22:29–37
  33. Antoni MH, Cruess DG, Cruess SE, Lutgendorf S, Kumar M, Ironson G, et al. Cognitive-behavioral stress management intervention effects on anxiety, 24-hour urinary norepinephrine output, and T-cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men. J Consult Clin Psychol. 2000;68:31–45
  34. Cole SW, Naliboff BD, Kemeny ME, Griswold MP, Fahey JL, Zack JA. Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Natl Acad Sci U S A. 2001;98:12695–12700
  35. Cole SW, Korin YD, Fahey JL, Zack JA. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol. 1998;161:610–616
  36. Cole SW, Jamieson BD, Zack JA. cAMP up-regulates cell surface expression of lymphocyte CXCR4: implications for chemotaxis and HIV-1 infection. J Immunol. 1999;162:1392–1400

PII: S0022-3999(08)00285-7

doi: 10.1016/j.jpsychores.2008.06.002

Journal of Psychosomatic Research
Volume 65, Issue 4 , Pages 389-401 , October 2008